Addex Therapeutics (ADXN) Short-term Investments: 2022-2025
Historic Short-term Investments for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $8,448.
- Addex Therapeutics' Short-term Investments rose 492.18% to $8,448 in Q2 2025 from the same period last year, while for Jun 2025 it was $8,448, marking a year-over-year increase of 492.18%. This contributed to the annual value of $7,384 for FY2024, which is 682.04% up from last year.
- Latest data reveals that Addex Therapeutics reported Short-term Investments of $8,448 as of Q2 2025, which was up 11.24% from $7,594 recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Short-term Investments ranged from a high of $3.1 billion in Q3 2023 and a low of -$15.1 billion during Q2 2023.
- In the last 3 years, Addex Therapeutics' Short-term Investments had a median value of $5,083 in 2023 and averaged -$1.2 billion.
- Data for Addex Therapeutics' Short-term Investments shows a peak YoY increase of 21,299,907.67% (in 2023) and a maximum YoY decrease of 107,076,456.91% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Addex Therapeutics' Short-term Investments stood at $3,285 in 2022, then slumped by 70.90% to $956.00 in 2023, then soared by 675.66% to $7,415 in 2024, then skyrocketed by 492.18% to $8,448 in 2025.
- Its Short-term Investments stands at $8,448 for Q2 2025, versus $7,594 for Q1 2025 and $7,415 for Q4 2024.